Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group.
about
Gender analysis of moxifloxacin clinical trialsWhat do the new antimicrobials offer? Weighing the advantages and disadvantages compared with traditional agents.Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.Evaluation and cost assessment of fluoroquinolones in community-acquired respiratory infections.Enrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection.Advances in the management of Chlamydia pneumoniae infections.Mycoplasma pneumoniae and its role as a human pathogen.A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).Fastidious intracellular bacteria as causal agents of community-acquired pneumonia.Moxifloxacin: a respiratory fluoroquinolone
P2860
Q28538319-A7A47AB4-E8BB-4E71-8454-4FA5AA8C7CCAQ34193591-C7ECBB54-FC6C-4B06-8239-563C32C2AE5FQ34240856-190BB3C3-C1C8-4246-B1FB-D057EE0BF557Q34789110-F052C9C1-3AC6-4116-BBDA-FCBCA2DD004EQ35175244-7F722972-9C13-4FDB-A2AF-EF4B659CAB1DQ35917262-03373452-ACE9-4C7C-879C-01C83249B558Q35920629-4C407D23-B68F-427E-88EC-79875668A17EQ37017387-CBD7C243-D01F-4349-9B79-C2BD60FA953EQ37768416-74C03637-B323-4BF5-B604-A889752283FAQ57778170-A09B4F6E-1774-4C9F-B0BD-DBA37270C2B6
P2860
Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of ten day ...... cquired Pneumonia Study Group.
@en
Efficacy and safety of ten day ...... cquired Pneumonia Study Group.
@nl
type
label
Efficacy and safety of ten day ...... cquired Pneumonia Study Group.
@en
Efficacy and safety of ten day ...... cquired Pneumonia Study Group.
@nl
prefLabel
Efficacy and safety of ten day ...... cquired Pneumonia Study Group.
@en
Efficacy and safety of ten day ...... cquired Pneumonia Study Group.
@nl
P2093
P356
P1433
P1476
Efficacy and safety of ten day ...... cquired Pneumonia Study Group.
@en
P2093
P304
P356
10.1053/RMED.1999.0710
P577
2000-02-01T00:00:00Z